Ubiquitylation of p53 by the APC/C inhibitor Trim39

被引:41
作者
Zhang, Liguo [1 ]
Huang, Nai-Jia [1 ]
Chen, Chen [1 ]
Tang, Wanli [1 ]
Kornbluth, Sally [1 ]
机构
[1] Duke Univ, Sch Med, Dept Pharmacol & Canc Biol, Durham, NC 27710 USA
基金
美国国家卫生研究院;
关键词
ANAPHASE-PROMOTING COMPLEX; MDM2; INHIBITOR; ACTIVATION; EMI1; CANCER; DEGRADATION; EXPRESSION; PATHWAY;
D O I
10.1073/pnas.1212047110
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Tripartite motif 39 (Trim39) is a RING domain-containing E3 ubiquitin ligase able to inhibit the anaphase-promoting complex (APC/C) directly. Through analysis of Trim39 function in p53-positive and p53-negative cells, we have found, surprisingly, that p53-positive cells lacking Trim39 could not traverse the G1/S transition. This effect did not result from disinhibition of the APC/C. Moreover, although Trim39 loss inhibited etoposide-induced apoptosis in p53-negative cells, apoptosis was enhanced by Trim39 knockdown in p53-positive cells. Furthermore, we show here that the Trim39 can directly bind and ubiquitylate p53 in vitro and in vivo, leading to p53 degradation. Depletion of Trim39 significantly increased p53 protein levels and cell growth retardation in multiple cell lines. We found that the relative importance of Trim39 and the well-characterized p53-directed E3 ligase, murine double minute 2 (MDM2), varied between cell types. In cells that were relatively insensitive to the MDM2 inhibitor, nutlin-3a, apoptosis could be markedly enhanced by siRNA directed against Trim39. As such, Trim39 may serve as a potential therapeutic target in tumors with WT p53 when MDM2 inhibition is insufficient to elevate p53 levels and apoptosis.
引用
收藏
页码:20931 / 20936
页数:6
相关论文
共 34 条
[1]   Trim24 targets endogenous p53 for degradation [J].
Allton, Kendra ;
Jain, Abhinav K. ;
Herz, Hans-Martin ;
Tsai, Wen-Wei ;
Jung, Sung Yun ;
Qin, Jun ;
Bergmann, Andreas ;
Johnson, Randy L. ;
Barton, Michelle Craig .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2009, 106 (28) :11612-11616
[2]   A Stapled p53 Helix Overcomes HDMX-Mediated Suppression of p53 [J].
Bernal, Federico ;
Wade, Mark ;
Godes, Marina ;
Davis, Tina N. ;
Whitehead, David G. ;
Kung, Andrew L. ;
Wahl, Geoffrey M. ;
Walensky, Loren D. .
CANCER CELL, 2010, 18 (05) :411-422
[3]   p53 regulation by ubiquitin [J].
Brooks, Christopher L. ;
Gu, Wei .
FEBS LETTERS, 2011, 585 (18) :2803-2809
[4]   Awakening guardian angels: drugging the p53 pathway [J].
Brown, Christopher J. ;
Lain, Sonia ;
Verma, Chandra S. ;
Fersht, Alan R. ;
Lane, David P. .
NATURE REVIEWS CANCER, 2009, 9 (12) :862-873
[5]   Differences in the ubiquitination of p53 by Mdm2 and the HPV protein E6 [J].
Camus, S ;
Higgins, M ;
Lane, DP ;
Lain, S .
FEBS LETTERS, 2003, 536 (1-3) :220-224
[6]   Inhibition of the anaphase-promoting complex by the Xnf7 ubiquitin ligase [J].
Casaletto, JB ;
Nutt, LK ;
Wu, QJ ;
Moore, JD ;
Etkin, LD ;
Jackson, PK ;
Hunt, T ;
Kornbluth, S .
JOURNAL OF CELL BIOLOGY, 2005, 169 (01) :61-71
[7]  
Hainaut P, 2000, ADV CANCER RES, V77, P81
[8]   Mdm2 promotes the rapid degradation of p53 [J].
Haupt, Y ;
Maya, R ;
Kazaz, A ;
Oren, M .
NATURE, 1997, 387 (6630) :296-299
[9]   Oncoprotein MDM2 is a ubiquitin ligase E3 for tumor suppressor p53 [J].
Honda, R ;
Tanaka, H ;
Yasuda, H .
FEBS LETTERS, 1997, 420 (01) :25-27
[10]   MDMX overexpression prevents p53 activation by the MDM2 inhibitor nutlin [J].
Hu, Baoli ;
Gilkes, Daniele M. ;
Farooqi, Bilal ;
Sebti, Said M. ;
Chen, Jiandong .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2006, 281 (44) :33030-33035